HC Wainwright Cuts Tango Therapeutics (NASDAQ:TNGX) Price Target to $13.00

Tango Therapeutics (NASDAQ:TNGX – Free Report) had its price target cut by HC Wainwright from $16.00 to $13.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Tango Therapeutics’ Q2 2024 earnings at ($0.36) EPS, Q3 2024 earnings […]

Related Keywords

China ,Piper Sandler ,Barclays ,China Universal Asset Management Co ,Tango Therapeutics Inc ,Pricet Rowe Associates Inc ,Mva Investors Llc ,Cantor Fitzgerald ,Tango Therapeutics Company Profile ,Securities Exchange Commission ,Paloma Partners Management Co ,Tango Therapeutics ,Free Report ,Get Free Report ,Mva Investors ,Exchange Commission ,China Universal Asset Management ,Universal Asset Management ,Tango Therapeutics Daily ,